Sandler D P, Shore D L, Anderson J R, Davey F R, Arthur D, Mayer R J, Silver R T, Weiss R B, Moore J O, Schiffer C A
Environmental and Molecular Epidemiology Section, National Institute of Environmental Health Sciences, Research Triangle Park, N.C.
J Natl Cancer Inst. 1993 Dec 15;85(24):1994-2003. doi: 10.1093/jnci/85.24.1994.
Cigarette smoking may be a risk factor for leukemia. No detailed biological mechanism has been proposed, but a causal link is made plausible by evidence of systemic effects of cigarette smoke and the presence in cigarette smoke of chemicals that have been associated with leukemia risk.
Our purpose was to investigate the leukemia risk associated with cigarette smoking in a multicenter case-control study of acute leukemias in adults.
Adults aged 18-79 with newly diagnosed leukemia were contacted to participate in this epidemiologic study when they entered a clinical trial to be treated under protocols sponsored by Cancer and Leukemia Group B. Smoking histories for 610 patients with acute leukemia and 618 population control subjects were obtained by telephone interviews. We examined bone marrow samples and classified patients by morphology of leukocyte precursor cells according to the French-American-British (FAB) classification system and, for 378 patients, by the presence or absence of specific clonal chromosome abnormalities. We calculated odds ratios (ORs) for risk of leukemia associated with smoking cigarettes. ORs were adjusted for age, race, and sex.
Smoking was associated with only a modest increase in risk for leukemia overall (adjusted OR = 1.13; 95% confidence interval [CI] = 0.89-1.44). However, among participants aged 60 and older, smoking was associated with a twofold increase in risk for acute myeloid leukemia (AML) (OR = 1.96; 95% CI = 1.17-3.28) and a threefold increase in risk for acute lymphocytic leukemia (ALL) (OR = 3.40; 95% CI = 0.97-11.9). Among older persons, risks increased with amount and duration of smoking. Smoking was associated with increased risk for AML classified as FAB type M2 at all ages, with ORs of 1.70 (95% CI = 1.00-2.90) for those younger than 60 and 3.50 (95% CI = 1.53-8.03) for those aged 60 and older. Smoking was also associated with ALL type L2 at all ages, with ORs of 1.72 (95% CI = 0.90-3.27) for those younger than 60 and 5.34 (95% CI = 1.03-27.6) for those who were older. Smoking was more common among patients with specific chromosome abnormalities in AML [-7 or 7q-, -Y, +13] and in ALL [t(9;22)(q34;q11)].
Cigarette smoking is associated with increased risk for leukemia and may lead to leukemias of specific morphologic and chromosomal types. The association varies with age.
Examining discrete subtypes of disease may permit more accurate assessment of risk. As standardized morphologic classification and cytogenetic and molecular evaluation of leukemia patients becomes more common, epidemiologic studies that take advantage of these advances will begin to contribute to the identification of additional risk factors and mechanisms in acute leukemia.
吸烟可能是白血病的一个风险因素。目前尚未提出详细的生物学机制,但鉴于香烟烟雾的全身效应证据以及香烟烟雾中存在与白血病风险相关的化学物质,两者之间的因果联系似乎合理。
我们的目的是在一项针对成人急性白血病的多中心病例对照研究中,调查与吸烟相关的白血病风险。
年龄在18 - 79岁、新诊断为白血病的成年人在进入由癌症与白血病B组赞助的临床试验接受治疗方案时,被联系参与这项流行病学研究。通过电话访谈获取了610例急性白血病患者和618名人群对照者的吸烟史。我们检查了骨髓样本,并根据法国 - 美国 - 英国(FAB)分类系统,依据白细胞前体细胞的形态对患者进行分类,对于378例患者,还根据是否存在特定的克隆染色体异常进行了分类。我们计算了与吸烟相关的白血病风险的比值比(OR)。OR针对年龄、种族和性别进行了调整。
总体而言,吸烟仅与白血病风险的适度增加相关(调整后的OR = 1.13;95%置信区间[CI] = 0.89 - 1.44)。然而,在60岁及以上的参与者中,吸烟与急性髓系白血病(AML)风险增加两倍相关(OR = 1.96;95% CI = 1.17 - 3.28),与急性淋巴细胞白血病(ALL)风险增加三倍相关(OR = 3.40;95% CI = 0.97 - 11.9)。在老年人中,风险随着吸烟量和吸烟持续时间的增加而增加。吸烟与所有年龄段被分类为FAB M2型的AML风险增加相关,60岁以下人群的OR为1.70(95% CI = 1.00 - 2.90),60岁及以上人群的OR为3.50(95% CI = 1.53 - 8.03)。吸烟在所有年龄段也与ALL L2型相关,60岁以下人群的OR为1.72(95% CI = 0.90 - 3.27),60岁及以上人群的OR为5.34(95% CI = 1.03 - 27.6)。吸烟在AML中具有特定染色体异常[-7或7q - 、-Y、+13]以及ALL中[t(9;22)(q34;q11)]的患者中更为常见。
吸烟与白血病风险增加相关,可能导致特定形态学和染色体类型的白血病。这种关联因年龄而异。
检查疾病的离散亚型可能有助于更准确地评估风险。随着白血病患者标准化形态学分类以及细胞遗传学和分子评估变得更加普遍,利用这些进展的流行病学研究将开始有助于识别急性白血病的其他风险因素和机制。